This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Injury of nerves at hip and thigh level
ST19_INJURY_NERVES_HIP_THIGH_LEVEL
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
135 |
4. Check minimum number of eventsNone |
135 |
5. Include endpointsNone |
135 |
6. Filter based on genotype QC (FinnGen only) |
135 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_HIP_THIGH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S7
- Name in latin
- Laesio nervorum regionis coxae/femoris
Similar endpoints
↥List of similar endpoints to
Injury of nerves at hip and thigh level
based on the number of shared cases.
Similar with more cases:
- Injuries to the hip and thigh
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 135 | 75 | 60 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 58.85 | 54.91 | 63.79 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 120
- Matched controls
- 1198
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S74.0
ICD-10 Finland
Injury of sciatic nerve at hip and thigh level
+∞
37.5
34
*
S74.1
ICD-10 Finland
Injury of femoral nerve at hip and thigh level
+∞
28.2
26
*
S74.9
ICD-10 Finland
Injury of unspecified nerve at hip and thigh level
+∞
26.0
24
*
S74.2
ICD-10 Finland
Injury of cutaneous sensory nerve at hip and thigh level
+∞
22.6
21
*
S74.8
ICD-10 Finland
Injury of other nerves at hip and thigh level
+∞
14.9
14
*
N03AX16
ATC
pregabalin; oral
5.2
14.8
58
183
X58
ICD-10 Finland
Exposure to other specified factors
6.9
14.4
39
78
N03AX12
ATC
gabapentin; oral
5.8
13.3
42
101
NE1AA
NOMESCO Finland
Pelvis X-ray examination
11.1
12.2
23
25
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
4.1
11.5
57
215
N02AX02
ATC
tramadol; systemic, rectal
3.7
10.8
73
352
NF1AA
NOMESCO Finland
Hip X-ray examination
7.2
10.2
25
42
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
22.4
10.1
14
7
NF3AA
NOMESCO Finland
Femur X-ray examination
108.2
9.6
10
*
N03AX09
ATC
lamotrigine; oral
13.0
9.4
16
14
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
5.7
9.2
27
58
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
54.0
8.8
10
*
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
+∞
8.4
8
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.2
8.2
58
269
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.3
8.1
25
57
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.5
7.5
27
72
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
12.0
7.5
13
12
S76.3
ICD-10 Finland
Injury of muscle and tendon of the posterior muscle group at thigh level
+∞
7.4
7
*
S72.0
ICD-10 Finland
Fracture of neck of femur
+∞
7.4
7
*
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
18.0
6.9
10
6
S70.0
ICD-10 Finland
Contusion of hip
24.1
6.8
9
*
N06AX16
ATC
venlafaxine; oral
3.7
6.7
30
98
R4110
NOMESCO Finland
Physiotherapy
3.1
6.7
43
185
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.6
6.5
31
107
ZXA00
NOMESCO Finland
Right side
2.9
6.5
46
209
M16.1
ICD-10 Finland
Other primary coxarthrosis
4.4
6.5
23
61
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
12.0
6.4
11
10
M79.6
ICD-10 Finland
Pain in limb
2.8
6.4
55
280
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
19.3
6.4
9
5
S72.3
ICD-10 Finland
Fracture of shaft of femur
+∞
6.3
6
*
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
6.2
6.3
16
29
B01AB05
ATC
enoxaparin; parenteral
2.8
6.2
49
236
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.8
6.2
47
221
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
4.1
6.2
24
69
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
86
512
2.87
8.00
5.2
4.1
—
—
—
0
0
11
21
5.61
5.63
1.7
1.7
—
—
—
0
0
46
233
2.48
5.49
1.8
1.8
0.56
1.44
mg/l
3.19
36
184
39
200
2.34
4.42
5.5
3.1
21.37
109.62
ng/l
1.87
30
155
18
66
2.99
3.94
3.1
4.7
25.35
24.36
mmol/l
0.48
18
66
46
264
2.13
3.92
3.8
2.5
—
—
—
0
0
76
548
1.89
3.22
7.2
6.6
1.22
1.21
mmol/l
0.42
65
463
11
34
3.43
3.13
1.4
2.0
—
—
—
0
0
57
379
1.87
3.08
2.5
3.1
27.40
33.91
u/l
1.21
57
361
30
164
2.07
2.83
1.5
1.9
—
—
—
0
0
29
157
2.08
2.80
4.4
5.6
105.03
104.41
mmol/l
0.45
29
152
5
6
8.59
2.77
1.0
1.3
—
—
—
0
0
51
338
1.82
2.72
3.5
3.0
0.22
0.49
e6/l
1.16
36
253
60
421
1.77
2.63
4.0
3.0
—
—
—
0
0
21
103
2.23
2.58
2.0
2.5
0.23
0.22
g/l
0.39
21
94
6
11
5.65
2.57
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
7
7.36
2.57
1.0
1.3
—
—
—
0
0
10
34
3.10
2.47
1.3
2.4
—
—
—
0
0
6
12
5.18
2.43
1.0
1.2
—
—
—
0
0
22
115
2.09
2.32
1.5
1.7
—
—
—
0
0
124
1107
2.47
2.26
23.7
14.4
24.88
21.74
mg/l
0.46
107
878
19
97
2.12
2.13
4.0
5.4
1.11
1.16
mmol/l
0.17
19
91
5
10
5.14
2.09
1.0
1.0
—
—
—
0
0
97
812
1.69
1.99
3.9
4.0
14.85
14.80
pmol/l
0.06
88
729
23
131
1.91
1.93
14.9
23.2
1.19
1.37
inr
—
7
18
23
131
1.91
1.93
4.0
4.5
217.30
257.55
u/l
1.18
23
124
58
432
1.60
1.89
3.9
3.8
19.35
46.49
ng/l
2.10
41
307
9
35
2.68
1.84
2.0
1.8
1.22
1.14
g/l
—
9
35
21
120
1.89
1.74
1.5
1.8
—
—
—
0
0
8
31
2.68
1.69
1.1
1.2
—
1.96
—
0
9
7
26
2.78
1.60
1.0
1.3
—
—
—
0
0
7
26
2.78
1.60
1.0
1.3
—
—
—
0
0
7
26
2.78
1.60
1.3
1.3
—
—
—
0
0
6
21
2.94
1.52
4.7
2.5
64.33
60.33
%
—
6
21
80
669
1.48
1.40
9.9
9.8
4.14
3.99
e9/l
0.18
67
579
5
17
3.01
1.37
1.4
1.1
—
—
—
0
0
9
42
2.22
1.36
1.4
1.9
—
—
—
0
0
40
293
1.52
1.34
5.5
3.9
0.06
0.00
estimate
0.48
18
109
28
189
1.61
1.33
4.0
3.2
3.13
2.54
e6/l
0.23
14
103
8
34
2.44
1.31
2.1
1.8
0.25
0.21
g/l
—
8
34
16
94
1.80
1.24
2.0
2.5
3.66
5.15
ug/l
0.34
16
83
18
110
1.73
1.23
1.6
4.3
6.09
5.59
kpa
0.84
18
105
23
151
1.63
1.22
5.1
5.9
1.07
1.07
mmol/l
0.02
18
135
6
26
2.37
1.20
1.2
1.2
—
—
—
0
0
95
837
1.46
1.17
5.5
4.2
14.65
11.78
mm/h
0.98
89
762
7
30
2.40
1.14
5.7
2.0
26.76
24.21
mmol/l
—
7
25
7
32
2.25
1.10
1.1
2.0
—
—
—
0
0
111
1014
1.53
1.08
5.2
4.7
1.81
1.91
mu/l
0.51
102
905
7
33
2.18
1.07
1.7
1.5
—
—
—
0
0
39
298
1.43
1.05
2.6
3.1
335.12
7565.93
umol/l
1.51
33
253
15
92
1.71
1.02
1.6
3.2
4.63
4.43
kpa
0.22
15
86
11
61
1.87
1.02
1.4
1.4
—
—
—
0
0
115
1063
1.55
1.01
19.3
13.6
82.17
80.96
ml/min/173m2
0.25
100
874
28
202
1.49
1.00
2.7
2.9
1.67
0.82
e6/l
1.07
15
116
9
50
1.86
0.99
4.2
1.7
—
—
—
0
0
18
119
1.59
0.94
4.2
3.8
—
—
—
0
0
6
29
2.12
0.90
1.8
1.5
—
0.12
—
0
6
10
56
1.85
0.90
1.4
3.9
25.70
23.80
mmol/l
—
10
51
9
54
1.71
0.76
1.4
1.7
—
—
—
0
0
51
428
1.31
0.75
4.6
3.9
—
—
—
0
0
14
93
1.56
0.73
6.9
3.2
55.00
64.74
ml/min/173m2
—
6
42
13
85
1.59
0.72
1.5
1.6
—
—
—
0
0
16
111
1.50
0.70
2.9
2.0
337.38
354.28
nmol/l
0.12
16
103
62
540
1.27
0.67
4.5
3.8
0.00
0.00
estimate
0.00
15
114
63
553
1.26
0.63
4.6
3.8
0.00
0.00
estimate
0.00
18
106
8
51
1.60
0.61
1.6
2.0
—
—
—
0
0
17
124
1.42
0.59
1.2
1.9
1.37
1.47
%
0.35
17
106
6
36
1.70
0.57
2.2
1.3
—
—
—
0
0
10
65
1.58
0.57
1.1
1.3
—
—
—
0
0
23
179
1.34
0.56
1.2
1.3
36.05
12.60
u/ml
—
8
72
9
60
1.54
0.55
3.0
3.3
4.59
4.36
pmol/l
—
9
53
32
262
1.29
0.55
1.5
1.3
1.67
1.47
u/ml
—
9
71
6
38
1.61
0.55
1.0
1.2
—
—
—
0
0
25
198
1.32
0.54
1.4
1.3
46.00
37.98
iu/ml
—
7
69
6
40
1.52
0.52
5.8
1.9
0.73
0.00
g/l
—
6
40
61
545
1.22
0.49
5.6
5.3
0.00
0.00
estimate
0.00
18
114
126
1223
1.45
0.46
32.2
21.1
260.17
250.11
e9/l
0.81
126
1193
126
1223
1.45
0.46
32.4
21.2
132.18
135.73
g/l
1.71
126
1203
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
5
35
1.44
0.39
2.6
2.0
—
—
—
0
0
49
438
1.19
0.38
2.5
2.0
89.64
94.83
pmol/l
0.37
29
219
6
44
1.38
0.35
1.5
1.9
—
—
—
0
0
32
279
1.19
0.32
3.2
5.0
24.76
22.31
%
0.40
16
153
7
52
1.36
0.32
1.0
1.2
—
—
—
0
0
7
52
1.36
0.32
1.0
1.2
—
—
—
0
0
62
663
0.88
0.27
3.3
3.1
—
—
—
0
0
5
37
1.36
0.24
1.6
2.5
—
—
—
0
0
5
39
1.29
0.23
6.2
1.9
0.00
0.00
g/l
—
5
39
5
39
1.29
0.23
6.2
1.9
0.00
0.00
g/l
—
5
39
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
128.97
—
0
10
0
14
0.00
0.20
0.0
4.1
—
33.19
—
0
14
78
753
1.08
0.14
3.9
3.3
45.17
50.05
u/l
0.37
72
703
108
1057
1.11
0.14
4.2
4.1
1.41
1.28
mmol/l
0.92
102
956
111
1088
1.11
0.14
4.3
4.6
5.87
5.95
mmol/l
0.39
105
989
46
437
1.08
0.12
3.2
2.4
75.45
78.06
nmol/l
0.24
40
386
101
990
1.08
0.10
20.9
14.9
38.59
39.95
%
0.77
68
712
17
155
1.11
0.09
1.4
1.4
—
—
—
0
0
37
352
1.07
0.09
3.8
5.4
1.78
2.60
ug/l
1.01
32
307
5
61
0.81
0.08
1.0
1.0
—
—
—
0
0
21
197
1.08
0.06
1.9
1.5
—
—
—
0
0
110
1091
1.04
0.03
4.6
4.6
1.43
1.47
mmol/l
0.46
103
992
113
1123
1.04
0.01
5.1
5.1
2.83
2.73
mmol/l
0.51
106
1021
30
306
0.97
0.00
1.5
1.7
1.65
1.37
mmol/l
0.51
24
264
34
346
0.98
0.00
5.8
4.0
13.73
8.04
mg/mmol
0.35
20
220
10
101
0.99
0.00
2.0
1.9
—
—
—
0
0
14
139
1.01
0.00
4.1
7.5
—
—
—
0
0
110
1095
1.02
0.00
4.7
4.6
4.76
4.63
mmol/l
0.60
105
1003
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
9
90
1.00
0.00
2.2
1.8
—
—
—
0
0
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
10.39
—
0
5
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
0
5
0.00
0.00
0.0
6.6
—
221.60
—
0
5
8
82
0.97
0.00
1.4
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
21
210
1.00
0.00
2.7
3.3
1.34
0.82
ug/l
0.42
14
147
0
7
0.00
0.00
0.0
2.6
—
55.00
—
0
7
0
5
0.00
0.00
0.0
1.2
—
0.34
—
0
5
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
11.38
—
0
5
0
7
0.00
0.00
0.0
4.4
—
58.43
—
0
7
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_INJURY_NERVES_HIP_THIGH_LEVEL – Injury of nerves at hip and thigh level
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).